For more than 40 years, Cincinnati Children’s has been a leader in caring for children with leukemia and lymphoma. Today, our Leukemia and Lymphoma Program is one of the nation’s largest and most technically advanced.
Our experienced cancer specialists treat children, adolescents and young adults who have been recently diagnosed with leukemia or lymphoma, and those with high-risk, treatment-resistant or recurrent cancer. Conditions we treat include:
- Acute myeloid leukemia (AML), also called myelogenous, granulocytic, myelocytic or myeloblastic leukemia
- Acute lymphoblastic leukemia (ALL), also called lymphocytic or lymphoid leukemia
- Hodgkin’s lymphoma
- Non-Hodgkin’s lymphoma, including both B- and T-cell subtypes
- Mixed phenotype acute leukemia (MPAL)
- Post-transplant lymphoma and lymphoproliferative disorder
- Myelodysplasia disorders, which are bone marrow disorders that can lead to acute myeloid leukemia
- Leukemia and lymphoma that occur in people who have an increased risk of developing these cancers, including people with Down syndrome and Fanconi anemia
Our care team creates a personalized treatment plan for each patient. The plan may include chemotherapy, radiation therapy, surgery to remove some or all of the tumor, novel immune therapies, and blood or marrow transplantation. Patients have access to both national clinical research studies as well as research studies only available at Cincinnati Children’s.